Amgen Deploys Veeva Vault CRM Globally for Faster Therapy Launches

Pharmaceutical giant Amgen has announced plans to deploy Veeva Vault CRM globally as part of its long-term collaboration with Veeva Systems. This move aims to accelerate the development and delivery of innovative medicines to patients worldwide by improving speed and agility in commercial operations.

Veeva Vault CRM, a part of the Vault CRM Suite, offers advanced tools to engage healthcare professionals and uncover treatment barriers, supporting Amgen's goal to launch new therapies effectively. The deployment underscores Amgen's commitment to leveraging technology to improve patient outcomes and address challenging diseases.

Amgen has seen its shares trade at USD 380.42 on the day, down 0.28%, while Veeva Systems' shares are trading at USD 263.00, down 1.01%. As of September 15, 2026, 18:13 WIB, Veeva's market cap stands at $43.01 billion and Amgen's at $206.25 billion.